Reactive oxygen species-mediated cardiac-reperfusion injury: Mechanisms and therapies

Life Sciences

Volumn 165, Issue , 2016, Pages 43-55

  Bagheri, Fereshte ^a   Khori, Vahid ^b   Alizadeh, Ali Mohammad ^c   Khalighfard, Solmaz ^d   Khodayari, Saeed ^c   Khodayari, Hamid ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Cardiac; Reperfusion; Review; ROS

Indexed keywords

ABELSON KINASE; ANTIOXIDANT; CALCIUM ION; CHAPERONE; JANUS KINASE; MANGANESE SUPEROXIDE DISMUTASE; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C GAMMA; PHOSPHOTYROSINE; PROTEIN KINASE C; PROTEIN SHC; REACTIVE OXYGEN METABOLITE; STAT PROTEIN;

HUMAN; ISCHEMIC PRECONDITIONING; MITOCHONDRION; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHASE 2 CLINICAL TRIAL (TOPIC); PROTEIN TARGETING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; METABOLISM; SIGNAL TRANSDUCTION;

HUMANS; MYOCARDIAL REPERFUSION INJURY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84988946002     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2016.09.013     Document Type: Review

References (164)

1. [1] Eltzschig, H.K., Eckle, T., Ischemia and reperfusion — from mechanism to translation. Nat. Med. 17 (2011), 1391–1401.
2. [2] Ebrahimi, S., Esfahani, S.A., Kohkiloezadeh, M., Moghaddam, B.H., Askarian, S., Tanideh, N., Tamadon, A., A model of cerebral ischemia induction in neonatal rabbits. JAAR 40 (2012), 37–42.
3. [3] Piper, H.M., Meuter, K., Schafer, C., Cellular mechanisms of ischemia-reperfusion injury. Ann. Thorac. Surg. 75 (2003), S644–S648.
4. [4] Tavakoli, F., Ostad, S.N., Khori, V., Alizadeh, A.M., Sadeghpour, A., Azar, A.D., Haghjoo, M., Zare, A., Nayebpour, M., Outcome improvement of cellular cardiomyoplasty using triple therapy: mesenchymal stem cell + erythropoietin + vascular endothelial growth factor. Eur. J. Pharmacol. 714 (2013), 456–463.
5. [5] Dorweiler, B., Pruefer, D., Andrasi, T.B., Maksan, S.M., Schmiedt, W., Neufang, A., Vahl, C.F., Ischemia-reperfusion injury. Eur. J. Trauma Emerg. Surg. 33 (2007), 600–612.
6. [6] Solaini, G., Harris, D.A., Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem. J. 390 (2005), 377–394.
7. [7] French, J.P., Quindry, J.C., Falk, D.J., Staib, J.L., Lee, Y., Wang, K.K., Powers, S.K., Ischemia-reperfusion-induced calpain activation and SERCA2a degradation are attenuated by exercise training and calpain inhibition. Am. J. Physiol. Heart Circ. Physiol. 290 (2006), H128–H136.
8. [8] Zweier, J.L., Talukder, M.H., The role of oxidants and free radicals in reperfusion injury. Cardiovasc. Res. 70 (2006), 181–190.
9. [9] Tawfik, M.K., Abo-ElMatty, D.M., Ahmed, A., The role of ATP-sensitive potassium channel blockers in ischemia-reperfusion-induced renal injury versus their effects on cardiac ischemia reperfusion in rats. Eur. Rev. Med. Pharmacol. Sci. 13 (2009), 81–93.
10. [10] Faghihi, M., Alizadeh, A.M., Khori, V., Latifpour, M., Khodayari, S., The role of nitric oxide, reactive oxygen species, and protein kinase C in oxytocin-induced cardioprotection in ischemic rat heart. Peptides 37 (2012), 314–319.
11. [11] Bassino, E., Fornero, S., Gallo, M.P., Gallina, C., Femminò, S., Levi, R., Tota, B., Alloatti, G., Catestatin exerts direct protective effects on rat cardiomyocytes undergoing ischemia/reperfusion by stimulating PI3K-Akt-GSK3β pathway and preserving mitochondrial membrane potential. PLoS One, 10, 2015, e0119790.
12. [12] Reynolds, A.C., Cellular and Molecular Responses in Striped Bass (Morone saxatilis) and Nile Tilapia (Oreochromis niloticus) Cardiomyocytes in Response to Hypoxia. 2015.
13. [13] Nasri, M., Alizadeh, A.M., Khori, V., Hajizadeh, S., Khodayari, S., A novel isolated dual perfusion/superfusion heart model for physiological and pharmacological evaluation of mammalian heart preparations. Physiol Pharmacol. 16 (2013), 340–349.
14. [14] Tanaka, T., Kawabata, K., Kakumoto, M., Hara, A., Murakami, A., Kuki, W., Takahashi, Y., Yonei, H., Maeda, M., Ota, T., Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: the inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes. Cancer Res. 58 (1998), 2550–2556.
15. [15] Kardeh, S., Ashkani-Esfahani, S., Alizadeh, A.M., Paradoxical action of reactive oxygen species in creation and therapy of cancer. Eur. J. Pharmacol. 735 (2014), 150–168.
16. [16] Kevin, L.G., Novalija, E., Stowe, D.F., Reactive oxygen species as mediators of cardiac injury and protection: the relevance to anesthesia practice. Anesth. Analg. 101 (2005), 1275–1287.
17. [17] Alizadeh, A.M., Faghihi, M., Sadeghipour, H.R., MohammadGhasemi, F., Khori, V., Role of endogenous oxytocin in cardiac ischemic preconditioning. Regul. Pept. 167 (2011), 86–90.
18. [18] Bernardi, P., Di Lisa, F., The mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotection. J. Mol. Cell. Cardiol. 78 (2015), 100–106.
19. [19] Murphy, E., Steenbergen, C., Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev. 88 (2008), 581–609.
20. [20] Heusch, G., Boengler, K., Schulz, R., Cardioprotection nitric oxide, protein kinases, and mitochondria. Circulation 118 (2008), 1915–1919.
21. [21] Kimura, S., Zhang, G.-X., Nishiyama, A., Shokoji, T., Yao, L., Fan, Y.-Y., Rahman, M., Suzuki, T., Maeta, H., Abe, Y., Role of NAD (P) H oxidase-and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Hypertension 45 (2005), 860–866.
22. [22] Zhang, G.-X., Lu, X.-M., Kimura, S., Nishiyama, A., Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation. Cardiovas. Res. 76 (2007), 204–212.
23. [23] Zhang, L., Tong, M., Xiao, M., Li, L., Ding, J., Nitric oxide mediates feedback inhibition in angiotensin II-induced upregulation of vasopressin mRNA. Peptides 30 (2009), 913–917.
24. [24] Di Lisa, F., Canton, M., Menabò, R., Kaludercic, N., Bernardi, P., Mitochondria and cardioprotection. Heart Fail. Rev. 12 (2007), 249–260.
25. [25] Madesh, M., Hajnóczky, G., VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. J. Cell Biol. 155 (2001), 1003–1016.
26. [26] Zhao, K., Zhao, G.-M., Wu, D., Soong, Y., Birk, A.V., Schiller, P.W., Szeto, H.H., Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J. Biol. Chem. 279 (2004), 34682–34690.
27. [27] Yellon, D.M., Hausenloy, D.J., Myocardial reperfusion injury. N. Engl. J. Med. 357 (2007), 1121–1135.
28. [28] Carden, D.L., Granger, D.N., Pathophysiology of ischaemia–reperfusion injury. J. Pathol. 190 (2000), 255–266.
29. [29] Pourkhalili, K., Hajizadeh, S., Akbari, Z., Dehaj, M.E., Akbarzadeh, S., Alizadeh, A., Bushehr, I., Hyperoxic preconditioning fails to confer additional protection against ischaemia–reperfusion injury in acute diabetic rat heart. EXCLI J. 11 (2012), 263–273.
30. [30] Rosca, M.G., Hoppel, C.L., Mitochondrial dysfunction in heart failure. Heart Fail. Rev. 18 (2013), 607–622.
31. [31] Di Lisa, F., Kaludercic, N., Carpi, A., Menabo, R., Giorgio, M., Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66Shc and monoamine oxidase. Basic Res. Cardiol. 104 (2009), 131–139.
32. [32] Webster, K.A., Mitochondrial membrane permeabilization and cell death during myocardial infarction: roles of calcium and reactive oxygen species. Futur. Cardiol. 8 (2012), 863–884.
33. [33] Di Lisa, F., Canton, M., Carpi, A., Kaludercic, N., Menabo, R., Menazza, S., Semenzato, M., Mitochondrial injury and protection in ischemic pre-and postconditioning. Antioxid. Redox Signal. 14 (2011), 881–891.
34. [34] Zorov, D.B., Juhaszova, M., Yaniv, Y., Nuss, H.B., Wang, S., Sollott, S.J., Regulation and pharmacology of the mitochondrial permeability transition pore. Cardiovasc. Res. 83 (2009), 213–225.
35. [35] Halestrap, A.P., Pasdois, P., The role of the mitochondrial permeability transition pore in heart disease. Biochimica et Biophysica Acta (BBA)-Bioenergetics 1787 (2009), 1402–1415.
36. [36] Perrelli, M.-G., Pagliaro, P., Penna, C., Ischemia/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species. World J. Cardiol. 3 (2011), 186–200.
37. [37] Luo, X., Budihardjo, I., Zou, H., Slaughter, C., Wang, X., Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94 (1998), 481–490.
38. [38] Shimizu, S., Narita, M., Tsujimoto, Y., Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399 (1999), 483–487.
39. [39] Farsinejad, S., Gheisary, Z., Samani, S.E., Alizadeh, A.M., Mitochondrial targeted peptides for cancer therapy. Tumor Biol. 36 (2015), 5715–5725.
40. [40] Chen, G.Y., Nunez, G., Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10 (2010), 826–837.
41. [41] Wu, J., Meng, Z., Jiang, M., Zhang, E., Trippler, M., Broering, R., Bucchi, A., Krux, F., Dittmer, U., Yang, D., Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific. Immunology 129 (2010), 363–374.
42. [42] Cheng, X.-L., Ding, F., Li, H., Tan, X.-Q., Liu, X., Cao, J.-M., Gao, X., Activation of AMPA receptor promotes TNF-α release via the ROS-cSrc-NFκB signaling cascade in RAW264. 7 macrophages. Biochem. Biophys. Res. Commun. 461 (2015), 275–280.
43. [43] Deng, S., Tang, S., Zhang, S., Zhang, C., Wang, C., Zhou, Y., Dai, C., Xiao, X., Furazolidone induces apoptosis through activating reactive oxygen species-dependent mitochondrial signaling pathway and suppressing PI3K/Akt signaling pathway in HepG2 cells. Food Chem. Toxicol. 75 (2015), 173–186.
44. [44] Hariharan, N., Ikeda, Y., Hong, C., Alcendor, R.R., Usui, S., Gao, S., Maejima, Y., Sadoshima, J., Autophagy plays an essential role in mediating regression of hypertrophy during unloading of the heart. PLoS One, 8, 2013, e51632.
45. [45] Nishida, K., Kyoi, S., Yamaguchi, O., Sadoshima, J., Otsu, K., The role of autophagy in the heart. Cell Death Dis. 16 (2009), 31–38.
46. [46] Laurindo, F.R., Pescatore, L.A., de Castro Fernandes, D., Protein disulfide isomerase in redox cell signaling and homeostasis. Free Radic. Biol. Med. 52 (2012), 1954–1969.
47. [47] Pedruzzi, E., Guichard, C., Ollivier, V., Driss, F., Fay, M., Prunet, C., Marie, J.-C., Pouzet, C., Samadi, M., Elbim, C., NAD (P) H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol. Cell. Biol. 24 (2004), 10703–10717.
48. [48] Alizadeh, A.M., Faghihi, M., Khori, V., Mohsenikia, M., Effect of pre-treatment with oxytocin on cardiac enzymes in regional ischemiareperfusion injury induced in the rat heart. Physiol. Pharmacol. 15 (2012), 572–582.
49. [49] Alizadeh, A.M., Faghihi, M., Khori, V., Sohanaki, H., Pourkhalili, K., Mohammadghasemi, F., Mohsenikia, M., Oxytocin protects cardiomyocytes from apoptosis induced by ischemia–reperfusion in rat heart: role of mitochondrial ATP-dependent potassium channel and permeability transition pore. Peptides 36 (2012), 71–77.
50. [50] Alizadeh, A.M., Faghihi, M., Sadeghipour, H.R., MohammadGhasemi, F., Imani, A., Houshmand, F., Khori, V., Oxytocin protects rat heart against ischemia–reperfusion injury via pathway involving mitochondrial ATP-dependent potassium channel. Peptides 31 (2010), 1341–1345.
51. [51] Alizadeh, A.M., Mirzabeglo, P., Is oxytocin a therapeutic factor for ischemic heart disease?. Peptides 45 (2013), 66–72.
52. [52] Ray, P.D., Huang, B.-W., Tsuji, Y., Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 24 (2012), 981–990.
53. [53] Zabbarova, I., Kanai, A., Targeted delivery of radioprotective agents to mitochondria. Mol. Interv., 8, 2008, 294.
54. [54] Giacco, F., Brownlee, M., Oxidative stress and diabetic complications. Circ. Res. 107 (2010), 1058–1070.
55. [55] Ozben, T., Free Radicals, Oxidative Stress, and Antioxidants: Pathological and Physiological Significance. 2013, Springer Science & Business Media.
56. [56] Zaja, I., Bai, X., Liu, Y., Kikuchi, C., Dosenovic, S., Yan, Y., Canfield, S.G., Bosnjak, Z.J., Cdk1, PKCδ and calcineurin-mediated Drp1 pathway contributes to mitochondrial fission-induced cardiomyocyte death. Biochem. Biophys. Res. Commun. 453 (2014), 710–721.
57. [57] Ai, Q., Sun, G., Luo, Y., Dong, X., Hu, R., Meng, X., Sun, X., Ginsenoside Rb1 prevents hypoxia-reoxygenation-induced apoptosis in H9c2 cardiomyocytes via an estrogen receptor-dependent crosstalk among the Akt, JNK, and ERK 1/2 pathways using a label-free quantitative proteomics analysis. RSC Adv. 5 (2015), 26346–26363.
58. [58] Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J., Greenberg, M.E., Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270, 1995, 1326.
59. [59] Bian, H.-J., Li, X.-X., Liu, X.-B., Sun, J.-P., Ji, X.-P., ERK-MAPK signaling opposes rho-kinase to reduce cardiomyocyte apoptosis in heart ischemic preconditioning. Mol. Med., 16, 2010.
60. [60] Junttila, M.R., Li, S.-P., Westermarck, J., Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J. 22 (2008), 954–965.
61. [61] Yokota, T., Wang, Y., p38 MAP kinases in the heart. Gene 575 (2016), 369–376.
62. [62] Sakamoto, K., Iwasaki, K., Sugiyama, H., Tsuji, Y., Role of the tumor suppressor PTEN in antioxidant responsive element-mediated transcription and associated histone modifications. Mol. Biol. Cell 20 (2009), 1606–1617.
63. [63] Salmeen, A., Andersen, J.N., Myers, M.P., Meng, T.-C., Hinks, J.A., Tonks, N.K., Barford, D., Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423 (2003), 769–773.
64. [64] Seifried, A., Bergeron, A., Boivin, B., Gohla, A., Reversible oxidation controls the activity and oligomeric state of the mammalian phosphoglycolate phosphatase AUM. Free Radic. Biol. Med. 97 (2016), 75–84.
65. [65] Kamata, H., Honda, S.-i., Maeda, S., Chang, L., Hirata, H., Karin, M., Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120 (2005), 649–661.
66. [66] Migliaccio, E., Giorgio, M., Pelicci, P.G., Apoptosis and aging: role of p66Shc redox protein. Antioxid. Redox Signal. 8 (2006), 600–608.
67. [67] Gertz, M., Steegborn, C., The lifespan-regulator p66Shc in mitochondria: redox enzyme or redox sensor?. Antioxid. Redox Signal. 13 (2010), 1417–1428.
68. [68] Seo, A.Y., Joseph, A.-M., Dutta, D., Hwang, J.C., Aris, J.P., Leeuwenburgh, C., New insights into the role of mitochondria in aging: mitochondrial dynamics and more. J. Cell Sci. 123 (2010), 2533–2542.
69. [69] Guo, Z., Kozlov, S., Lavin, M.F., Person, M.D., Paull, T.T., ATM activation by oxidative stress. Science 330 (2010), 517–521.
70. [70] Guo, Y.-L., Chakraborty, S., Rajan, S.S., Wang, R., Huang, F., Effects of oxidative stress on mouse embryonic stem cell proliferation, apoptosis, senescence, and self-renewal. Stem Cells Dev. 19 (2010), 1321–1331.
71. [71] Baines, C.P., Zhang, J., Wang, G.-W., Zheng, Y.-T., Xiu, J.X., Cardwell, E.M., Bolli, R., Ping, P., Mitochondrial PKCε and MAPK form signaling modules in the murine heart enhanced mitochondrial PKCε-MAPK interactions and differential MAPK activation in PKCε-induced cardioprotection. Circ. Res. 90 (2002), 390–397.
72. [72] Ogbi, M., Johnson, J.A., Protein kinase Cϵ interacts with cytochrome c oxidase subunit IV and enhances cytochrome c oxidase activity in neonatal cardiac myocyte preconditioning. Biochem. J. 393 (2006), 191–199.
73. [73] Jaburek, M., Costa, A.D., Burton, J.R., Costa, C.L., Garlid, K.D., Mitochondrial PKCε and mitochondrial ATP-sensitive K + channel copurify and coreconstitute to form a functioning signaling module in proteoliposomes. Circ. Res. 99 (2006), 878–883.
74. [74] Otani, H., Reactive oxygen species as mediators of signal transduction in ischemic preconditioning. Antioxid. Redox Signal. 6 (2004), 449–469.
75. 2 inhibit the mitochondrial permeability transition. J. Biol. Chem. 281 (2006), 20801–20808.
76. [76] Petronilli, V., Penzo, D., Scorrano, L., Bernardi, P., Di Lisa, F., The mitochondrial permeability transition, release of cytochrome c and cell death correlation with the duration of pore openings in situ. J. Biol. Chem. 276 (2001), 12030–12034.
77. [77] Hamasaki, Y., Shinohara, O., Ishida, H., Hayashi, Y., Nakazawa, H., Decreased protein kinase C-epsilon expression in hypertrophied cardiac ventricles induced by triiodothyronine treatment in the rat. Life Sci. 67 (2000), 1859–1868.
78. [78] Choi, D.-S., Wang, D., Yu, G.-Q., Zhu, G., Kharazia, V.N., Paredes, J.P., Chang, W.S., Deitchman, J.K., Mucke, L., Messing, R.O., PKCε increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic mice. Proc. Natl. Acad. Sci. 103 (2006), 8215–8220.
79. [79] Zuo, L., Roberts, W.J., Tolomello, R.C., Goins, A.T., Ischemic and hypoxic preconditioning protect cardiac muscles via intracellular ROS signaling. Front. Biol. 8 (2013), 305–311.
80. [80] Kalogeris, T., Bao, Y., Korthuis, R.J., Mitochondrial reactive oxygen species: a double edged sword in ischemia/reperfusion vs preconditioning. Redox Biol. 2 (2014), 702–714.
81. [81] Garlid, K.D., Dos Santos, P., Xie, Z.-J., Costa, A.D., Paucek, P., Mitochondrial potassium transport: the role of the mitochondrial ATP-sensitive K + channel in cardiac function and cardioprotection. Biochim. Biophys. Acta 1606 (2003), 1–21.
82. [82] Gross, G.J., Hsu, A., Falck, J.R., Nithipatikom, K., Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts. J. Mol. Cell. Cardiol. 42 (2007), 687–691.
83. [83] Visser, D., Middelbeek, J., van Leeuwen, F.N., Jalink, K., Function and regulation of the channel-kinase TRPM7 in health and disease. Eur. J. Cell Biol. 93 (2014), 455–465.
84. [84] Banan, A., Fields, J., Zhang, Y., Keshavarzian, A., Phospholipase C-γ inhibition prevents EGF protection of intestinal cytoskeleton and barrier against oxidants. Am. J. Physiol. Gastrointest. Liver Physiol. 281 (2001), G412–G423.
85. [85] Smith, C.C., Dixon, R.A., Wynne, A.M., Theodorou, L., Ong, S.-G., Subrayan, S., Davidson, S.M., Hausenloy, D.J., Yellon, D.M., Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore. Am. J. Physiol. Gastrointest. Liver Physiol. 299 (2010), H1265–H1270.
86. [86] You, L., Li, L., Xu, Q., Ren, J., Zhang, F., Postconditioning reduces infarct size and cardiac myocyte apoptosis via the opioid receptor and JAK-STAT signaling pathway. Mol. Biol. Rep. 38 (2011), 437–443.
87. [87] Hantschel, O., Superti-Furga, G., Regulation of the c-Abl and Bcr–Abl tyrosine kinases. Nat. Rev. Mol. Cell Biol. 5 (2004), 33–44.
88. [88] Kumar, S., Bharti, A., Mishra, N.C., Raina, D., Kharbanda, S., Saxena, S., Kufe, D., Targeting of the c-Abl tyrosine kinase to mitochondria in the necrotic cell death response to oxidative stress. J. Biol. Chem. 276 (2001), 17281–17285.
89. [89] Ito, Y., Pandey, P., Mishra, N., Kumar, S., Narula, N., Kharbanda, S., Saxena, S., Kufe, D., Targeting of the c-Abl tyrosine kinase to mitochondria in endoplasmic reticulum stress-induced apoptosis. Mol. Cell. Biol. 21 (2001), 6233–6242.
90. [90] Qi, X., Mochly-Rosen, D., The PKCδ-Abl complex communicates ER stress to the mitochondria–an essential step in subsequent apoptosis. J. Cell Sci. 121 (2008), 804–813.
91. [91] Wang, X., Yuan, B., Dong, W., Yang, B., Yang, Y., Lin, X., Gong, G., Induction of heat-shock protein 70 expression by geranylgeranylacetone shows cytoprotective effects in cardiomyocytes of mice under humid heat stress. PLoS One, 9, 2014, e93536.
92. [92] Condorelli, G., Latronico, M.V., Cavarretta, E., microRNAs in cardiovascular diseases: current knowledge and the road ahead. J. Am. Coll. Cardiol. 63 (2014), 2177–2187.
93. [93] Ren, X.-P., Wu, J., Wang, X., Sartor, M.A., Qian, J., Jones, K., Nicolaou, P., Pritchard, T.J., Fan, G.-C., MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 119 (2009), 2357–2366.
94. [94] Kurapeev, D.I., Kabanov, V.O., Grebennik, V.K., Sheshurina, T.A., Dorofeykov, V.V., Galagudza, M.M., Shlyakhto, E.V., New technique of local ischemic preconditioning induction without repetitive aortic cross-clamping in cardiac surgery. J. Cardiothorac. Surg., 10, 2015, 1.
95. [95] Das, S., Ferlito, M., Kent, O.A., Fox-Talbot, K., Wang, R., Liu, D., Raghavachari, N., Yang, Y., Wheelan, S.J., Murphy, E., Nuclear miRNA regulates the mitochondrial genome in the heart. Circ. Res. 110 (2012), 1596–1603.
96. [96] Yang, J., Chen, L., Yang, J., Ding, J., Li, S., Wu, H., Zhang, J., Fan, Z., Dong, W., Li, X., MicroRNA-22 targeting CBP protects against myocardial ischemia–reperfusion injury through anti-apoptosis in rats. Mol. Biol. Rep. 41 (2014), 555–561.
97. [97] He, B., Xiao, J., Ren, A.-J., Zhang, Y.-F., Zhang, H., Chen, M., Xie, B., Gao, X.-G., Wang, Y.-W., Role of miR-1 and miR-133a in myocardial ischemic postconditioning. J. Biomed. Sci., 18, 2011, 1.
98. [98] Tang, Y., Zheng, J., Sun, Y., Wu, Z., Liu, Z., Huang, G., MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int. Heart J. 50 (2009), 377–387.
99. [99] Choi, E., Cha, M.-J., Hwang, K.-C., Roles of calcium regulating microRNAs in cardiac ischemia-reperfusion injury. Cells 3 (2014), 899–913.
100. [100] Arosio, P., Michaels, T.C., Linse, S., Månsson, C., Emanuelsson, C., Presto, J., Johansson, J., Vendruscolo, M., Dobson, C.M., Knowles, T.P., Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation. Nat. Commun., 7, 2016.
101. [101] Cvoro, A., Korac, A., Matic, G., Intracellular localization of constitutive and inducible heat shock protein 70 in rat liver after in vivo heat stress. Mol. Cell. Biochem. 265 (2004), 27–35.
102. [102] Fink, A.L., Chaperone-mediated protein folding. Physiol. Rev. 79 (1999), 425–449.
103. [103] Minowada, G., Welch, W.J., Clinical implications of the stress response. J. Clin. Investig., 95, 1995, 3.
104. [104] Mosser, D.D., Caron, A.W., Bourget, L., Meriin, A.B., Sherman, M.Y., Morimoto, R.I., Massie, B., The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol. Cell. Biol. 20 (2000), 7146–7159.
105. [105] Brown, C.R., Martin, R.L., Hansen, W.J., Beckmann, R.P., Welch, W.J., The constitutive and stress inducible forms of hsp 70 exhibit functional similarities and interact with one another in an ATP-dependent fashion. J. Cell Biol. 120 (1993), 1101–1112.
106. [106] Jaattela, M., Wissing, D., Kokholm, K., Kallunki, T., Egeblad, M., Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J. 17 (1998), 6124–6134.
107. [107] Kayama, M., Nakazawa, T., Thanos, A., Morizane, Y., Murakami, Y., Theodoropoulou, S., Abe, T., Vavvas, D., Miller, J.W., Heat shock protein 70 (HSP70) is critical for the photoreceptor stress response after retinal detachment via modulating anti-apoptotic Akt kinase. Am. J. Pathol. 178 (2011), 1080–1091.
108. [108] Iwaki, K., Chi, S.-H., Dillmann, W.H., Mestril, R., Induction of HSP70 in cultured rat neonatal cardiomyocytes by hypoxia and metabolic stress. Circulation 87 (1993), 2023–2032.
109. [109] Ishii, H., Arai, T., Mori, H., Yamada, H., Endo, N., Makino, K., Fukuda, K., Protective effects of intracellular reactive oxygen species generated by 6-formylpterin on tumor necrosis factor-α-induced apoptotic cell injury in cultured rat hepatocytes. Life Sci. 77 (2005), 858–868.
110. [110] Salminen, W.F., Voellmy, R., Roberts, S.M., Protection against hepatotoxicity by a single dose of amphetamine: the potential role of heat shock protein induction. Toxicol. Appl. Pharmacol. 147 (1997), 247–258.
111. [111] Chen, H.W., Chien, C.T., Yu, S.L., Lee, Y.T., Chen, W.J., Cyclosporine A regulate oxidative stress-induced apoptosis in cardiomyocytes: mechanisms via ROS generation, iNOS and Hsp70. Br. J. Pharmacol. 137 (2002), 771–781.
112. [112] Feng, Y., Huang, W., Meng, W., Jegga, A.G., Wang, Y., Cai, W., Kim, H.W., Pasha, Z., Wen, Z., Rao, F., Heat shock improves Sca-1 + stem cell survival and directs ischemic cardiomyocytes toward a prosurvival phenotype via exosomal transfer: a critical role for HSF1/miR-34a/HSP70 pathway. Stem Cells 32 (2014), 462–472.
113. [113] Kornfeld, O.S., Hwang, S., Disatnik, M.-H., Chen, C.-H., Qvit, N., Mochly-Rosen, D., Mitochondrial reactive oxygen species at the heart of the matter new therapeutic approaches for cardiovascular diseases. Circ. Res. 116 (2015), 1783–1799.
114. [114] Dikalova, A.E., Bikineyeva, A.T., Budzyn, K., Nazarewicz, R.R., McCann, L., Lewis, W., Harrison, D.G., Dikalov, S.I., Therapeutic targeting of mitochondrial superoxide in hypertension. Circ. Res. 107 (2010), 106–116.
115. [115] Braunersreuther, V., Jaquet, V., Reactive oxygen species in myocardial reperfusion injury: from physiopathology to therapeutic approaches. Curr. Pharm. Biotechnol. 13 (2012), 97–114.
116. [116] Kloner, R.A., Rezkalla, S.H., Preconditioning, postconditioning and their application to clinical cardiology. Cardiovasc. Res. 70 (2006), 297–307.
117. [117] Schulz, R., Kelm, M., Heusch, G., Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc. Res. 61 (2004), 402–413.
118. [118] Abete, P., Cacciatore, F., Testa, G., Della-Morte, D., Galizia, G., Ferrara, N., Rengo, F., Clinical application of ischemic preconditioning in the elderly. Dose-Response, 8, 2010 (dose-response. 09-023. Abete).
119. [119] Pashkow, F.J., Oxidative stress and inflammation in heart disease: do antioxidants have a role in treatment and/or prevention?. Int. J. Inflamm., 2011, 2011.
120. [120] Zahler, S., Kupatt, C., Becker, B.F., Endothelial preconditioning by transient oxidative stress reduces inflammatory responses of cultured endothelial cells to TNF-α. FASEB J. 14 (2000), 555–564.
121. [121] Dave, K.R., DeFazio, R.A., Raval, A.P., Torraco, A., Saul, I., Barrientos, A., Perez-Pinzon, M.A., Ischemic preconditioning targets the respiration of synaptic mitochondria via protein kinase Cε. J. Neurosci. 28 (2008), 4172–4182.
122. [122] Brookes, P.S., Yoon, Y., Robotham, J.L., Anders, M., Sheu, S.-S., Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol. 287 (2004), C817–C833.
123. [123] Weerateerangkul, P., Chattipakorn, S., Chattipakorn, N., Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia-reperfusion injury. Med. Sci. Monit. Basic Res. 17 (2011), RA44–RA52.
124. [124] Walters, A.M., Porter, G.A., Brookes, P.S., Mitochondria as a drug target in ischemic heart disease and cardiomyopathy. Circ. Res. 111 (2012), 1222–1236.
125. [125] Khori, V., Alizadeh, A., Navaiyan, A., Nayebpour, M., Porabouk, M., Badaghabadi, F., Changizi, S., Rajaei, M., Moheimani, H., Yazdi, H., Role of nitric oxide on the electrophysiological properties of isolated rabbit atrioventricular node by extracellular field potential during atrial fibrillation. Physiol. Pharmacol. 15 (2011), 295–307.
126. [126] Khori, V., Alizadeh, A.M., Yazdi, H., Rakhshan, E., Mirabbasi, A., Changizi, S., Mazandarani, M., Nayebpour, M., Frequency-dependent electrophysiological remodeling of the AV node by hydroalcohol extract of Crocus sativus L.(saffron) during experimental atrial fibrillation: the role of endogenous nitric oxide. Phytother. Res. 26 (2012), 826–832.
127. [127] Kadenbach, B., Arnold, S., Lee, I., Hüttemann, M., The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases. Biochimica et Biophysica Acta (BBA)-Bioenergetics 1655 (2004), 400–408.
128. [128] Al Ghouleh, I., Khoo, N.K., Knaus, U.G., Griendling, K.K., Touyz, R.M., Thannickal, V.J., Barchowsky, A., Nauseef, W.M., Kelley, E.E., Bauer, P.M., Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling. Free Radic. Biol. Med. 51 (2011), 1271–1288.
129. [129] Cheng, Y., Zhu, P., Yang, J., Liu, X., Dong, S., Wang, X., Chun, B., Zhuang, J., Zhang, C., Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc. Res. 87 (2010), 431–439.
130. [130] Litt, J.Z., Litt's Cardiac Drug Eruptions and Interactions. 2005, CRC Press.
131. [131] Seifried, H., Anderson, D., Milner, J., Greenwald, P., Reactive Oxygen Species and Dietary Antioxidants: Double-edged Swords, New Developments in Antioxidant Research. 1-25, 2006, Nova Science Publishers Inc., Hauppauge, NY.
132. [132] Goszcz, K., Deakin, S.J., Duthie, G.G., Stewart, D., Leslie, S.J., Megson, I.L., Antioxidants in cardiovascular therapy: panacea or false hope?. Front. Cardiovasc. Med., 2, 2015.
133. [133] Adlam, V.J., Harrison, J.C., Porteous, C.M., James, A.M., Smith, R.A., Murphy, M.P., Sammut, I.A., Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J. 19 (2005), 1088–1095.
134. [134] Niki, E., Do antioxidants impair signaling by reactive oxygen species and lipid oxidation products?. FEBS Lett. 586 (2012), 3767–3770.
135. [135] Glantzounis, G.K., Salacinski, H.J., Yang, W., Davidson, B.R., Seifalian, A.M., The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transpl. 11 (2005), 1031–1047.
136. [136] Prabhu, A., Sujatha, D., Kanagarajan, N., Vijayalakshmi, M., Ninan, B., Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Ann. Vasc. Surg. 23 (2009), 645–651.
137. [137] Hamanaka, R.B., Chandel, N.S., Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem. Sci. 35 (2010), 505–513.
138. [138] Candas, D., Li, J.J., MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx. Antioxid. Redox Signal. 20 (2014), 1599–1617.
139. [139] Wispe, J.R., Clark, J.C., Burhans, M.S., Kropp, K.E., Korfhagen, T.R., Whitsett, J.A., Synthesis and processing of the precursor for human mangano-superoxide dismutase. Biochimica et Biophysica Acta (BBA)-Protein Struct. Mol. Enzymol. 994 (1989), 30–36.
140. [140] Jin, Z.-Q., Zhou, H.-Z., Cecchini, G., Gray, M.O., Karliner, J.S., MnSOD in mouse heart: acute responses to ischemic preconditioning and ischemia-reperfusion injury. Am. J. Phys. Heart Circ. Phys. 288 (2005), H2986–H2994.
141. [141] Musekove, V., Kander, R., Vogtelek, P., Skalickd, J., Vankove, R., Cegan, A., Cervinkove, Z., Antioxidant vitamin levels and glutathione peroxidase activity during ischemia/reperfusion in myocardial infarction. Physiol. Res. 50 (2001), 389–396.
142. [142] Bhabak, K.P., Mugesh, G., Functional mimics of glutathione peroxidase: bioinspired synthetic antioxidants. Acc. Chem. Res. 43 (2010), 1408–1419.
143. [143] Nagy, N., Malik, G., Fisher, A.B., Das, D.K., Targeted disruption of peroxiredoxin 6 gene renders the heart vulnerable to ischemia-reperfusion injury. Am. J. Phys. Heart Circ. Phys. 291 (2006), H2636–H2640.
144. [144] Venardos, K., Harrison, G., Headrick, J., Perkins, A., Effects of dietary selenium on glutathione peroxidase and thioredoxin reductase activity and recovery from cardiac ischemia–reperfusion. J. Trace Elem. Med. Biol. 18 (2004), 81–88.
145. [145] Quintana-Cabrera, R., Fernandez-Fernandez, S., Bobo-Jimenez, V., Escobar, J., Sastre, J., Almeida, A., Bolanos, J.P., γ-Glutamylcysteine detoxifies reactive oxygen species by acting as glutathione peroxidase-1 cofactor. Nat. Commun., 3, 2012, 718.
146. [146] Khori, V., Davarian, A., Nayebpour, M., Salaki, S., Salehi, A., Shirafkan, A.A., Badaghabadi, F., Pourabouk, M., Alizadeh, A.M., Changizi, S., Effect of nitric oxide modulation on the basic and rate-dependent electrophysiological properties of AV-node in the isolated heart of rabbit: the role of adrenergic and cholinergic receptors. Physiol. Pharmacol. 14 (2010), 12–22.
147. [147] Khori, V., Shariatnejad, S., Alizadeh, A., Yazdi, H., Pourabouk, M., Badaghabadi, F., Moheimani, H.R., Changizi, S., Rajee, M., Nayebpour, M., Protective role of cyclosporine on the model simulated the rotational nodal arrhythmia (AVNRT) by using extracellular field potential recordings of isolated atrioventricular-node of rabbit. Physiol. Pharmacol. 15 (2011), 249–259.
148. [148] Mohanakumar, K.P., Thomas, B., Sharma, S.M., Muralikrishnan, D., Chowdhury, R., Chiueh, C.C., Nitric oxide. Ann. N. Y. Acad. Sci. 962 (2002), 389–401.
149. [149] Weerateerangkul, P., Chattipakorn, S., Chattipakorn, N., Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia-reperfusion injury. Med. Sci. Monit. 17 (2011), RA44–RA52.
150. [150] Ono, H., Osanai, T., Ishizaka, H., Hanada, H., Kamada, T., Onodera, H., Fujita, N., Sasaki, S., Matsunaga, T., Okumura, K., Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation. Am. Heart J., 148, 2004, 611.
151. [151] Ishii, H., Ichimiya, S., Kanashiro, M., Amano, T., Imai, K., Murohara, T., Matsubara, T., Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment–elevation myocardial infarction. Circulation 112 (2005), 1284–1288.
152. [152] Bice, J.S., Jones, B.R., Chamberlain, G.R., Baxter, G.F., Nitric oxide treatments as adjuncts to reperfusion in acute myocardial infarction: a systematic review of experimental and clinical studies. Basic Res. Cardiol. 111 (2016), 1–15.
153. [153] Jones, D.A., Pellaton, C., Velmurugan, S., Rathod, K.S., Andiapen, M., Antoniou, S., van Eijl, S., Webb, A.J., Westwood, M.A., Parmar, M.K., Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction. Circ. Res. 116 (2015), 437–447.
154. [154] Jenkins, D.P., Pugsley, W.B., Alkhulaifi, A.M., Kemp, M., Hooper, J., Yellon, D.M., Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 77 (1997), 314–318.
155. [155] Szmagala, P., Morawski, W., Krejca, M., Gburek, T., Bochenek, A., Evaluation of perioperative myocardial tissue damage in ischemically preconditioned human heart during aorto coronary bypass surgery. J. Cardiovasc. Surg., 39, 1998, 791.
156. [156] Teoh, L., Grant, R., Hulf, J., Pugsley, W., Yellon, D., The effect of preconditioning (ischemic and pharmacological) on myocardial necrosis following coronary artery bypass graft surgery. Cardiovasc. Res. 53 (2002), 175–180.
157. [157] Cook, N.R., Albert, C.M., Gaziano, J.M., Zaharris, E., MacFadyen, J., Danielson, E., Buring, J.E., Manson, J.E., A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch. Intern. Med. 167 (2007), 1610–1618.
158. [158] Rodrigo, R., Hasson, D., Prieto, J.C., Dussaillant, G., Ramos, C., Leon, L., Garate, J., Valls, N., Gormaz, J.G., The effectiveness of antioxidant vitamins C and E in reducing myocardial infarct size in patients subjected to percutaneous coronary angioplasty (PREVEC Trial): study protocol for a pilot randomized double-blind controlled trial. Trials, 15, 2014, 192.
159. [159] Yesilbursa, D., Serdar, A., Senturk, T., Serdar, Z., Sag, S., Cordan, J., Effect of N-acetylcysteine on oxidative stress and ventricular function in patients with myocardial infarction. Heart Vessel. 21 (2006), 33–37.
160. [160] Coghlan, J., Flitter, W., Clutton, S., Panda, R., Daly, R., Wright, G., Ilsley, C., Slater, T., Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 107 (1994), 248–256.
161. [161] Knothe, C., Boldt, J., Zickmann, B., Ballesteros, M., Haufler, G., Bruns, F., Hempelmann, G., Cardiac protection in heart surgery interventions by preventive drug administration before extracorporeal circulation. Studies with troponin T as a parameter for perioperative myocardial damage. Herz 18 (1993), 379–386.
162. [162] Hannes, W., Seitelberger, R., Christoph, M., Keilich, M., Kulinna, C., Holubarsch, C., Fasol, R., Effect of peri-operative diltiazem on myocardial ischaemia and function in patients receiving mammary artery grafts. Eur. Heart J. 16 (1995), 87–93.
163. [163] Siddiqi, N., Neil, C., Bruce, M., MacLennan, G., Cotton, S., Papadopoulou, S., Feelisch, M., Bunce, N., Lim, P.O., Hildick-Smith, D., Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI). Eur. Heart J., 2014, ehu096.
164. [164] Borlaug, B.A., Koepp, K.E., Melenovsky, V., Sodium nitrite improves exercise hemodynamics and ventricular performance in heart failure with preserved ejection fraction. J. Am. Coll. Cardiol. 66 (2015), 1672–1682.